Breo Ellipta vs Advair Diskus — Comparison & Availability

Breo ElliptaAdvair Diskus
Brand NameBreo ElliptaAdvair Diskus
Generic Namefluticasone furoate/vilanterolfluticasone/salmeterol
Drug ClassICS/LABAICS/LABA
Findability Score61/10061/100
FindabilityModerateModerate
Avg Pharmacy Calls~10~10

Which Is Easier to Find Right Now?

Both Breo Ellipta and Advair Diskus have similar findability scores of 61/100. You may need to call around 10 pharmacies to locate either one. Let FindUrMeds do the searching for you.

Key Differences Between Breo Ellipta and Advair Diskus

Both Breo Ellipta (fluticasone furoate/vilanterol) and Advair Diskus (fluticasone/salmeterol) belong to the ICS/LABA drug class. While they share a similar mechanism of action, they may differ in dosing schedules, side effect profiles, and how individual patients respond to each. Your doctor can help determine which is the better fit based on your specific needs.

Frequently Asked Questions

Is Breo Ellipta or Advair Diskus easier to find?

Based on current availability data, Breo Ellipta has a Findability Score of 61/100 compared to Advair Diskus's 61/100. Breo Ellipta typically requires about 10 pharmacy calls to locate, while Advair Diskus may take around 10 calls.

Can I switch from Breo Ellipta to Advair Diskus?

Switching between Breo Ellipta and Advair Diskus requires a conversation with your prescribing doctor. They can evaluate whether the switch is appropriate based on your medical history, current condition, and how you've responded to your current medication. Never switch medications without medical guidance.

Which is cheaper, Breo Ellipta or Advair Diskus?

Prices vary by pharmacy, insurance coverage, and whether a generic is available. Breo Ellipta (generic: fluticasone furoate/vilanterol) and Advair Diskus (generic: fluticasone/salmeterol) may have different out-of-pocket costs depending on your plan. Using GoodRx coupons or asking your pharmacist about generic alternatives can help reduce costs for either medication.

Summarize this article with AI:

Learn More